Clinical trials: Cellulite
Cellulite
A Study to Assess the Adverse Events and Effectiveness of Rapid Acoustic Pulse (RAP) Device in Adult Participants for the Appearance of Cellulite
Cellulite is the rippling or dimpling of the skin most commonly located on the thighs and buttocks of women. Its appearance and texture are often likened to that of "cottage cheese" or an orange peel.
- Trial name
- NCT05730335
- Testing
- Rapid Acoustic Pulse
- Where
- 4 sites in United States
- Volunteers
- 59 people
- Sponsor
- Zeltiq Aesthetics
Edematous Fibrosclerotic Panniculopathy, Cellulite
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
An open-label study of safety and effectiveness of EN3835 in the treatment of cellulite in adult women.
- Trial name
- NCT03329989
- Testing
- Collagenase Clostridium Histolyticum
- Where
- 11 sites in United States
- Volunteers
- 158 people
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
Cellulite
Radio Frequency (RF) Device for Reduction in Size of Localized Areas of the Body
The purpose of this study is to evaluate the Cutera radio frequency (RF) device for the new indication of reduction in size of localized areas of the body.
- Trial name
- NCT00953160
- Testing
- Cutera Radio Frequency Device
- Where
- 5 sites in United States
- Volunteers
- 76 people
- Sponsor
- Cutera Inc.
Cellulite
Study of the Effect of Low Level Laser Light Therapy on Reducing the Appearance of Cellulite in the Thighs and Buttocks.
The purpose of this study is to determine whether the application of green diode low level laser light therapy is effective in reducing the appearance of cellulite in the thighs and buttocks.
- Trial name
- NCT01702259
- Testing
- Erchonia Scanner device (GLS)
- Where
- 2 sites in United States
- Volunteers
- 68 people, healthy volunteers welcome
- Sponsor
- Erchonia Corporation
Cellulite
Safety and Effectiveness of Poly-l-lactic Acid (PLLA) for the Improvement in Appearance of Cellulite
This pilot study has been designed to evaluate the safety and effectiveness of PLLA as a single regimen for the improvement in appearance of cellulite after changes in reconstitution procedure.
- Trial name
- NCT05064761
- Testing
- Sculptra new dilution
- Where
- Canada
- Volunteers
- 29 people, healthy volunteers welcome
- Sponsor
- Galderma R&D
Cellulite
Cryolipolysis and Subcision for Treatment of Cellulite
This study intended to investigate and compare the changes that may occur in response to cryolipolysis (localized cool exposure) and subcision (surgical technique) on cellulite.
- Trial name
- NCT01209767
- Testing
- cryolipolysis, Subcision, Control
- Where
- United States
- Volunteers
- 22 people, healthy volunteers welcome
- Sponsor
- Northwestern University
Cellulite
A Study to Assess the Adverse Events and Effectiveness of Rapid Acoustic Pulse (RAP) Device for the Appearance of Cellulite in Adult Participants
Cellulite is the rippling or dimpling of the skin most commonly located on the thighs and buttocks of women. Its appearance and texture are often likened to that of "cottage cheese" or an orange peel.
- Trial name
- NCT05664581
- Testing
- Rapid Acoustic Pulse
- Where
- United States
- Volunteers
- 14 people
- Sponsor
- Zeltiq Aesthetics
Reduction of Localized Excess Fat
Thigh Circumference Reduction Study
The purpose of this study is to evaluate the Cutera radio frequency (RF) device for the new indication of reduction of thigh circumference.
- Trial name
- NCT00953290
- Testing
- Cutera Radio Frequency Device
- Where
- United States
- Volunteers
- 4 people
- Sponsor
- Cutera Inc.
Edematous Fibrosclerotic Panniculopathy, Cellulite
Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite)
A Phase 3b, Open-Label Extension Study to evaluate safety and how long response of EN3835 (Collagenase Clostridium Histolyticum [CCH]-aaes) lasts in the treatment of Cellulite.
- Trial name
- NCT03526549
- Testing
- CCH-aaes, Observation
- Where
- 42 sites in United States
- Volunteers
- 483 people
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
Edematous Fibrosclerotic Panniculopathy
Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP
This study will evaluate the safety and Pharmacokinetics (PK) of a single 3.36-mg dose of Collagenase Clostridium Histolyticum (CCH) in 4 quadrants concurrently, in subjects with Edematous fibrosclerotic panniculopathy (EFP).
- Trial name
- NCT03675685
- Testing
- CCH (collagenase clostridium histolyticum)
- Where
- United States
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
Cellulite
To Assess the Effectiveness of Multiple Dose, Multiple Concentrations of Qwo, for the Treatment of Mild to Moderate Cellulite.
This is a single center, off-label, multiple dose, multiple injection areas, Phase 4 study to assess the safety and efficacy of multi-dilution CCH in adult women with mild or moderate edematous fibrosclerotic panniculopathy…
- Trial name
- NCT05026216
- Testing
- Qwo
- Where
- United States
- Volunteers
- 5 people, healthy volunteers welcome
- Sponsor
- DMR Research, PLLC
Cellulite
A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 2)
The Stage 2 of this phase 2 study is an open-label, single-arm study to assess the efficacy and safety of CBL-514 in participants with Edematous Fibrosclerotic Panniculopathy (EFP) cellulite.
- Trial name
- NCT05836779
- Testing
- CBL-514 injection
- Where
- 5 sites in United States
- Volunteers
- 23 people
- Sponsor
- Caliway Biopharmaceuticals Co., Ltd.
Treatment for Cellulite on the Stomach and Flanks
Multi-Center Pilot Study of Cutera truSculpt Device
Exploratory study to evaluate the safety, efficacy and ergonomics of Cutera truSculpt device.
- Trial name
- NCT03782545
- Testing
- Cutera truSculpt Device
- Where
- 3 sites in United States
- Volunteers
- 34 people, healthy volunteers welcome
- Sponsor
- Cutera Inc.
Cellulite
Profound Dermal and SubQ Cartridges for the Treatment of Cellulite
Clinical Study to Evaluate the Performance of the Profound System for the Treatment of Cellulite.
- Trial name
- NCT03078647
- Testing
- Profound
- Where
- 2 sites in United States
- Volunteers
- 31 people, healthy volunteers welcome
- Sponsor
- Syneron Medical
Edematous Fibrosclerotic Panniculopathy (EFP), Cellulite
Real World CCH Study in Adult Females With Cellulite
This is a multicenter, open-label, multiple dose, 2 cohort, Phase 3b study to assess the safety and efficacy of CCH in adult women with mild or moderate edematous fibrosclerotic panniculopathy (EFP).
- Trial name
- NCT04170296
- Testing
- EN3835
- Where
- 12 sites in United States, Puerto Rico
- Volunteers
- 153 people, healthy volunteers welcome
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
Cellulite, Edematous Fibrosclerotic Panniculopathy (EFP)
Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Women
This is a single center, open-label, Phase 2a study to assess the photonumeric scale, morphological, and histopathological changes associated with Collagenase Clostridium Histolyticum (CCH) in adult women with moderate or severe…
- Trial name
- NCT04209530
- Testing
- EN3835
- Where
- United States
- Volunteers
- 7 people, healthy volunteers welcome
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
Cellulite of Thighs
Clinical Evaluation of CelluTite Treatment
This prospective study is intended to evaluate the CelluTite RFAL handpiece combined with Morpheus8 handpiece for the treatment of cellulite.
- Trial name
- NCT03769649
- Testing
- CelluTite
- Where
- United States
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- InMode MD Ltd.
Edematous Fibrosclerotic Panniculopathy, Cellulite
CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques
This study is designed to investigate the safety and efficacy of collagenase clostridium histolyticum (CCH) for the treatment of mild to moderate edematous fibrosclerotic panniculopathy (cellulite) in participants with moderate…
- Conditions
- Edematous Fibrosclerotic Panniculopathy, Cellulite, Laxity; Skin
- Trial name
- NCT04580303
- Testing
- collagenase clostridium histolyticum
- Where
- 3 sites in United States
- Volunteers
- 35 people, healthy volunteers welcome
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
Body Fat Disorder
Effects on Cellulite Appearance
Evaluate the safety and feasibility effecting the appearance of cellulite on the thigh using CoolSculpting.
- Trial name
- EFC (NCT04876118)
- Testing
- The ZELTIQ System
- Where
- 6 sites in United States
- Volunteers
- 97 people, healthy volunteers welcome
- Sponsor
- Zeltiq Aesthetics
Edematous Fibrosclerotic Panniculopathy (EFP)
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
To assess the safety and effectiveness of repeat doses of AA4500 in the treatment of edematous fibrosclerotic panniculopathy (EFP) commonly known as cellulite in adult women.
- Trial name
- NCT01987986
- Testing
- Collagenase Clostridium Histolyticum
- Where
- 10 sites in United States
- Volunteers
- 150 people
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company